Mon, 27-Jun-2022

Oncology

VUNO Med LungCT AI Receives MFDS Regulatory Approval

VUNO, a member company of the Born2Global Centre, announced that the first CT based pulmonary nodule detecting AI solution in Korea, “VUNO Med-LungCT AI”, was approved by the Ministry of Food and Drug S... April 29, 2020 8:22 am By Neha Mule

Novartis Kymriah Receives FDA Regenerative Medicine ...

Novartis today announced that the US Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to Kymriah (tisagenlecleucel), for an investigational new indication t... April 22, 2020 6:37 am By Neha Mule

Indivumed, Personalis Partner to Enhance Genomic Seq...

Indivumed GmbH and Personalis, Inc. today announced that the two companies have entered into a collaboration in the field of personalized oncology. The partnership seeks to enable novel discoveries in cancer b... April 21, 2020 8:41 am By Neha Mule

Innovent Biologics Announces FDA Approval of Pemazyr...

Innovent Biologics, Inc., a biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announ... April 20, 2020 5:11 am By Neha Mule

Biofourmis Expands into Oncology Market with Strateg...

Biofourmis announced today it has finalized an agreement to acquire Gaido Health from Takeda Pharmaceuticals, a strategic deal that expands Biofourmis’ portfolio in the oncology space. Gaido Health—a Los ... April 16, 2020 11:29 am By Neha Mule

Samsung Biologics Partners with PharmAbcine for Onco...

Samsung Biologics entered into a strategic partnership with PharmAbcine for the development and manufacturing of PMC-402 pipeline, a next generation therapeutic antibody candidate to treat oncology and neovasc... April 6, 2020 5:59 am By Neha Mule

ImaginAb Announces Licensing Deal with AstraZeneca f...

ImaginAb Inc., a clinical stage immuno-oncology imaging company, today announced it has signed a multi-year non-exclusive license agreement with AstraZeneca. Under the terms of the agreement, ImaginAb... March 30, 2020 1:34 pm By Neha Mule

Related News